THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc. provides analytical instruments, laboratory equipment, consumables, reagents, and diagnostic test systems, alongside outsourced contract development and manufacturing services. The company reports its operations across four primary business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Key product offerings span biosciences, genetic analysis tools, chromatography and mass spectrometry systems, electron microscopes, clinical diagnostics, and comprehensive laboratory supplies. Thermo Fisher sells these offerings to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, research institutions, government agencies, and industrial and environmental testing facilities.

The company operates globally through direct sales forces, technical specialists, e-commerce channels, and third-party distributors. Its workforce totals approximately 125,000 employees worldwide, comprising about 59,000 colleagues in the Americas, 44,000 across Europe, the Middle East, and Africa, and 22,000 in the Asia-Pacific region. Sales operations are supported by approximately 14,000 dedicated sales personnel. The provided text does not state the company's headquarters location.

Summary of the business section of Thermo Fisher Scientific's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, we employed approximately 125,000 colleagues globally, with an approximate regional distribution as follows: 59,000 based in the Americas, 22,000 in the Asia-Pacific region, and 44,000 in Europe, the Middle East and Africa (EMEA).”